Overexpression of p67phox in Response to Fluoropyrimidines in HCT116 Cells

Home Page
About
Submit A Journal
Submit A Conference
Submit Paper/Book
- Submit a Preprint
- Submit a Book
Contact

Dicle Tıp Dergisi
Volume:43 Issue:4
Overexpression of p67phox in Response to Fluoropyrimidines in HCT116 Cells

Overexpression of p67phox in Response to Fluoropyrimidines in HCT116 Cells

Authors : Ufuk Ozer, Karen Wood Barbour

Pages : 490-489

View : 63 | Download : 12

Publication Date : 2016-12-25

Article Type : Research Paper

Abstract :Objectives: Cancer cells require reactive oxygen species (ROS) in order to keep up with growth rate. The accumulation of ROS induced by anticancer drugs can promote cell death through oxidative damage. A potential source of ROS is the family of NADPH oxidase (NOX) enzyme that produces ROS as their sole function. In this study, we aimed to investigate expression of NOX1 and NOX2 subunits in response to fluoropyrimidines in human colon cancer cell line, HCT116. Methods: We used fluoropyrimidines, 5-fluorouracil (FUra) and 5’-fluoro-2’-deoxyuridine (FdUrd) as anticancer drugs, and measured mRNA levels of NOX1 and NOX2 with semi-quantitative polymerase chain reaction (PCR), quantitative PCR (qPCR) and microarray assays in order. Results: We found that expression of none of enzyme subunits was altered in response to FUra or FdUrd, except expression of p67phox. Expression of p67phox was induced by drugs approximately 25-fold relative to basal level. Conclusion: p67phox subunit may be a key subunit in NOX-mediated ROS production following exposure to drugs.
Keywords : NADPH Oxidase, p67phox, ROS, colon cancer

ORIGINAL ARTICLE URL

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.